Cholinergic status modulations in human volunteers under acute inflammation
Cholinergic Status, the total soluble circulation capacity for acetylcholine hydrolysis, was tested for putative involvement in individual variabilities of the recruitment of immune cells in response to endotoxin challenge. Young (average age 26) and elderly (average age 70) volunteers injected with...
Gespeichert in:
Veröffentlicht in: | Journal of molecular medicine (Berlin, Germany) Germany), 2007-11, Vol.85 (11), p.1239-1251 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1251 |
---|---|
container_issue | 11 |
container_start_page | 1239 |
container_title | Journal of molecular medicine (Berlin, Germany) |
container_volume | 85 |
creator | OFEK, Keren KRABBE, Karen S EVRON, Tama DEBECCO, Meir NIELSEN, Anders R BRUNNSGAAD, Helle YIRMIYA, Raz SOREQ, Hermona PEDERSEN, Bente K |
description | Cholinergic Status, the total soluble circulation capacity for acetylcholine hydrolysis, was tested for putative involvement in individual variabilities of the recruitment of immune cells in response to endotoxin challenge. Young (average age 26) and elderly (average age 70) volunteers injected with either Escherichia coli endotoxin or saline on two different occasions were first designated Enhancers and Suppressors if they showed increase or decrease, respectively, in plasma acetylcholinesterase (AChE) activity 1.5 h after endotoxin administration compared to saline. Enhancers showed significant co-increases in plasma butyrylcholinesterase (BChE) and paraoxonase (PON1) activities, accompanied by rapid recovery of lymphocyte counts. Young Enhancers alone showed pronounced post-exposure increases in the pro-inflammatory cytokine interleukin-6 (IL-6), and upregulation of the normally rare, stress-induced AChE-R variant, suggesting age-associated exhaustion of the cholinergic effects on recruiting innate immune reactions to endotoxin challenge. Importantly, IL-6 injected to young volunteers or administered in vitro to primary mononuclear blood cells caused upregulation of AChE, but not BChE or PON1, excluding it from being the sole cause for this extended response. Interestingly, Suppressors but not Enhancers showed improved post-exposure working memory performance, indicating that limited cholinergic reactions may be beneficial for cognition. Our findings establish Cholinergic Status modulations as early facilitators and predictors of individual variabilities in the peripheral response to infection. |
doi_str_mv | 10.1007/s00109-007-0226-x |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68417775</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68417775</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-51e913e83efb75dd53faf9b9c54915e5ca291a7bf870589b6c35f4e3faa30c113</originalsourceid><addsrcrecordid>eNpd0F1LwzAUBuAgipvTH-CNFEHvqjlt0iSXMvzCgTd6HdI0cR1tqkkj89-bucHAqxzI8x4OL0LngG8AY3YbMAYs8jTmuCiqfH2ApkDKIgdC8CGaYkGqvGBQTdBJCKukGRXkGE2AVZSRik3Ry3w5dK0z_qPVWRjVGEPWD03s1NgOLmSty5axVy77HrroRmN8yKJrjM-UjqNJ_7ZTff-nT9GRVV0wZ7t3ht4f7t_mT_ni9fF5frfIdUmrMadgBJSGl8bWjDYNLa2yohaaEgHUUK0KAYrVljNMuairFLPEJKVKrAHKGbre7v30w1c0YZR9G7TpOuXMEIOsOAHGGE3w8h9cDdG7dJssUgWcC1wkBFuk_RCCN1Z--rZX_kcClpua5bZmuRk3Nct1ylzsFse6N80-ses1gasdUEGrznrldBv2ToBgnOPyF4WKhjI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>217688902</pqid></control><display><type>article</type><title>Cholinergic status modulations in human volunteers under acute inflammation</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>OFEK, Keren ; KRABBE, Karen S ; EVRON, Tama ; DEBECCO, Meir ; NIELSEN, Anders R ; BRUNNSGAAD, Helle ; YIRMIYA, Raz ; SOREQ, Hermona ; PEDERSEN, Bente K</creator><creatorcontrib>OFEK, Keren ; KRABBE, Karen S ; EVRON, Tama ; DEBECCO, Meir ; NIELSEN, Anders R ; BRUNNSGAAD, Helle ; YIRMIYA, Raz ; SOREQ, Hermona ; PEDERSEN, Bente K</creatorcontrib><description>Cholinergic Status, the total soluble circulation capacity for acetylcholine hydrolysis, was tested for putative involvement in individual variabilities of the recruitment of immune cells in response to endotoxin challenge. Young (average age 26) and elderly (average age 70) volunteers injected with either Escherichia coli endotoxin or saline on two different occasions were first designated Enhancers and Suppressors if they showed increase or decrease, respectively, in plasma acetylcholinesterase (AChE) activity 1.5 h after endotoxin administration compared to saline. Enhancers showed significant co-increases in plasma butyrylcholinesterase (BChE) and paraoxonase (PON1) activities, accompanied by rapid recovery of lymphocyte counts. Young Enhancers alone showed pronounced post-exposure increases in the pro-inflammatory cytokine interleukin-6 (IL-6), and upregulation of the normally rare, stress-induced AChE-R variant, suggesting age-associated exhaustion of the cholinergic effects on recruiting innate immune reactions to endotoxin challenge. Importantly, IL-6 injected to young volunteers or administered in vitro to primary mononuclear blood cells caused upregulation of AChE, but not BChE or PON1, excluding it from being the sole cause for this extended response. Interestingly, Suppressors but not Enhancers showed improved post-exposure working memory performance, indicating that limited cholinergic reactions may be beneficial for cognition. Our findings establish Cholinergic Status modulations as early facilitators and predictors of individual variabilities in the peripheral response to infection.</description><identifier>ISSN: 0946-2716</identifier><identifier>EISSN: 1432-1440</identifier><identifier>DOI: 10.1007/s00109-007-0226-x</identifier><identifier>PMID: 17657467</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>Acetylcholinesterase - genetics ; Acetylcholinesterase - metabolism ; Acute Disease ; Adult ; Aged ; Attention - drug effects ; Biological and medical sciences ; Biomarkers - metabolism ; Butyrylcholinesterase - metabolism ; Choline - metabolism ; Endotoxins - pharmacology ; General aspects ; Humans ; Immunity, Innate - drug effects ; Inflammation - metabolism ; Interleukin-6 - administration & dosage ; Interleukin-6 - pharmacology ; Male ; Medical sciences ; Memory - drug effects ; Recombinant Proteins - administration & dosage ; Recombinant Proteins - pharmacology ; Up-Regulation - drug effects</subject><ispartof>Journal of molecular medicine (Berlin, Germany), 2007-11, Vol.85 (11), p.1239-1251</ispartof><rights>2007 INIST-CNRS</rights><rights>Springer-Verlag 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-51e913e83efb75dd53faf9b9c54915e5ca291a7bf870589b6c35f4e3faa30c113</citedby><cites>FETCH-LOGICAL-c356t-51e913e83efb75dd53faf9b9c54915e5ca291a7bf870589b6c35f4e3faa30c113</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19197880$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17657467$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>OFEK, Keren</creatorcontrib><creatorcontrib>KRABBE, Karen S</creatorcontrib><creatorcontrib>EVRON, Tama</creatorcontrib><creatorcontrib>DEBECCO, Meir</creatorcontrib><creatorcontrib>NIELSEN, Anders R</creatorcontrib><creatorcontrib>BRUNNSGAAD, Helle</creatorcontrib><creatorcontrib>YIRMIYA, Raz</creatorcontrib><creatorcontrib>SOREQ, Hermona</creatorcontrib><creatorcontrib>PEDERSEN, Bente K</creatorcontrib><title>Cholinergic status modulations in human volunteers under acute inflammation</title><title>Journal of molecular medicine (Berlin, Germany)</title><addtitle>J Mol Med (Berl)</addtitle><description>Cholinergic Status, the total soluble circulation capacity for acetylcholine hydrolysis, was tested for putative involvement in individual variabilities of the recruitment of immune cells in response to endotoxin challenge. Young (average age 26) and elderly (average age 70) volunteers injected with either Escherichia coli endotoxin or saline on two different occasions were first designated Enhancers and Suppressors if they showed increase or decrease, respectively, in plasma acetylcholinesterase (AChE) activity 1.5 h after endotoxin administration compared to saline. Enhancers showed significant co-increases in plasma butyrylcholinesterase (BChE) and paraoxonase (PON1) activities, accompanied by rapid recovery of lymphocyte counts. Young Enhancers alone showed pronounced post-exposure increases in the pro-inflammatory cytokine interleukin-6 (IL-6), and upregulation of the normally rare, stress-induced AChE-R variant, suggesting age-associated exhaustion of the cholinergic effects on recruiting innate immune reactions to endotoxin challenge. Importantly, IL-6 injected to young volunteers or administered in vitro to primary mononuclear blood cells caused upregulation of AChE, but not BChE or PON1, excluding it from being the sole cause for this extended response. Interestingly, Suppressors but not Enhancers showed improved post-exposure working memory performance, indicating that limited cholinergic reactions may be beneficial for cognition. Our findings establish Cholinergic Status modulations as early facilitators and predictors of individual variabilities in the peripheral response to infection.</description><subject>Acetylcholinesterase - genetics</subject><subject>Acetylcholinesterase - metabolism</subject><subject>Acute Disease</subject><subject>Adult</subject><subject>Aged</subject><subject>Attention - drug effects</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - metabolism</subject><subject>Butyrylcholinesterase - metabolism</subject><subject>Choline - metabolism</subject><subject>Endotoxins - pharmacology</subject><subject>General aspects</subject><subject>Humans</subject><subject>Immunity, Innate - drug effects</subject><subject>Inflammation - metabolism</subject><subject>Interleukin-6 - administration & dosage</subject><subject>Interleukin-6 - pharmacology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Memory - drug effects</subject><subject>Recombinant Proteins - administration & dosage</subject><subject>Recombinant Proteins - pharmacology</subject><subject>Up-Regulation - drug effects</subject><issn>0946-2716</issn><issn>1432-1440</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpd0F1LwzAUBuAgipvTH-CNFEHvqjlt0iSXMvzCgTd6HdI0cR1tqkkj89-bucHAqxzI8x4OL0LngG8AY3YbMAYs8jTmuCiqfH2ApkDKIgdC8CGaYkGqvGBQTdBJCKukGRXkGE2AVZSRik3Ry3w5dK0z_qPVWRjVGEPWD03s1NgOLmSty5axVy77HrroRmN8yKJrjM-UjqNJ_7ZTff-nT9GRVV0wZ7t3ht4f7t_mT_ni9fF5frfIdUmrMadgBJSGl8bWjDYNLa2yohaaEgHUUK0KAYrVljNMuairFLPEJKVKrAHKGbre7v30w1c0YZR9G7TpOuXMEIOsOAHGGE3w8h9cDdG7dJssUgWcC1wkBFuk_RCCN1Z--rZX_kcClpua5bZmuRk3Nct1ylzsFse6N80-ses1gasdUEGrznrldBv2ToBgnOPyF4WKhjI</recordid><startdate>20071101</startdate><enddate>20071101</enddate><creator>OFEK, Keren</creator><creator>KRABBE, Karen S</creator><creator>EVRON, Tama</creator><creator>DEBECCO, Meir</creator><creator>NIELSEN, Anders R</creator><creator>BRUNNSGAAD, Helle</creator><creator>YIRMIYA, Raz</creator><creator>SOREQ, Hermona</creator><creator>PEDERSEN, Bente K</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20071101</creationdate><title>Cholinergic status modulations in human volunteers under acute inflammation</title><author>OFEK, Keren ; KRABBE, Karen S ; EVRON, Tama ; DEBECCO, Meir ; NIELSEN, Anders R ; BRUNNSGAAD, Helle ; YIRMIYA, Raz ; SOREQ, Hermona ; PEDERSEN, Bente K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-51e913e83efb75dd53faf9b9c54915e5ca291a7bf870589b6c35f4e3faa30c113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Acetylcholinesterase - genetics</topic><topic>Acetylcholinesterase - metabolism</topic><topic>Acute Disease</topic><topic>Adult</topic><topic>Aged</topic><topic>Attention - drug effects</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - metabolism</topic><topic>Butyrylcholinesterase - metabolism</topic><topic>Choline - metabolism</topic><topic>Endotoxins - pharmacology</topic><topic>General aspects</topic><topic>Humans</topic><topic>Immunity, Innate - drug effects</topic><topic>Inflammation - metabolism</topic><topic>Interleukin-6 - administration & dosage</topic><topic>Interleukin-6 - pharmacology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Memory - drug effects</topic><topic>Recombinant Proteins - administration & dosage</topic><topic>Recombinant Proteins - pharmacology</topic><topic>Up-Regulation - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>OFEK, Keren</creatorcontrib><creatorcontrib>KRABBE, Karen S</creatorcontrib><creatorcontrib>EVRON, Tama</creatorcontrib><creatorcontrib>DEBECCO, Meir</creatorcontrib><creatorcontrib>NIELSEN, Anders R</creatorcontrib><creatorcontrib>BRUNNSGAAD, Helle</creatorcontrib><creatorcontrib>YIRMIYA, Raz</creatorcontrib><creatorcontrib>SOREQ, Hermona</creatorcontrib><creatorcontrib>PEDERSEN, Bente K</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of molecular medicine (Berlin, Germany)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>OFEK, Keren</au><au>KRABBE, Karen S</au><au>EVRON, Tama</au><au>DEBECCO, Meir</au><au>NIELSEN, Anders R</au><au>BRUNNSGAAD, Helle</au><au>YIRMIYA, Raz</au><au>SOREQ, Hermona</au><au>PEDERSEN, Bente K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cholinergic status modulations in human volunteers under acute inflammation</atitle><jtitle>Journal of molecular medicine (Berlin, Germany)</jtitle><addtitle>J Mol Med (Berl)</addtitle><date>2007-11-01</date><risdate>2007</risdate><volume>85</volume><issue>11</issue><spage>1239</spage><epage>1251</epage><pages>1239-1251</pages><issn>0946-2716</issn><eissn>1432-1440</eissn><abstract>Cholinergic Status, the total soluble circulation capacity for acetylcholine hydrolysis, was tested for putative involvement in individual variabilities of the recruitment of immune cells in response to endotoxin challenge. Young (average age 26) and elderly (average age 70) volunteers injected with either Escherichia coli endotoxin or saline on two different occasions were first designated Enhancers and Suppressors if they showed increase or decrease, respectively, in plasma acetylcholinesterase (AChE) activity 1.5 h after endotoxin administration compared to saline. Enhancers showed significant co-increases in plasma butyrylcholinesterase (BChE) and paraoxonase (PON1) activities, accompanied by rapid recovery of lymphocyte counts. Young Enhancers alone showed pronounced post-exposure increases in the pro-inflammatory cytokine interleukin-6 (IL-6), and upregulation of the normally rare, stress-induced AChE-R variant, suggesting age-associated exhaustion of the cholinergic effects on recruiting innate immune reactions to endotoxin challenge. Importantly, IL-6 injected to young volunteers or administered in vitro to primary mononuclear blood cells caused upregulation of AChE, but not BChE or PON1, excluding it from being the sole cause for this extended response. Interestingly, Suppressors but not Enhancers showed improved post-exposure working memory performance, indicating that limited cholinergic reactions may be beneficial for cognition. Our findings establish Cholinergic Status modulations as early facilitators and predictors of individual variabilities in the peripheral response to infection.</abstract><cop>Berlin</cop><pub>Springer</pub><pmid>17657467</pmid><doi>10.1007/s00109-007-0226-x</doi><tpages>13</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0946-2716 |
ispartof | Journal of molecular medicine (Berlin, Germany), 2007-11, Vol.85 (11), p.1239-1251 |
issn | 0946-2716 1432-1440 |
language | eng |
recordid | cdi_proquest_miscellaneous_68417775 |
source | MEDLINE; Springer Nature - Complete Springer Journals |
subjects | Acetylcholinesterase - genetics Acetylcholinesterase - metabolism Acute Disease Adult Aged Attention - drug effects Biological and medical sciences Biomarkers - metabolism Butyrylcholinesterase - metabolism Choline - metabolism Endotoxins - pharmacology General aspects Humans Immunity, Innate - drug effects Inflammation - metabolism Interleukin-6 - administration & dosage Interleukin-6 - pharmacology Male Medical sciences Memory - drug effects Recombinant Proteins - administration & dosage Recombinant Proteins - pharmacology Up-Regulation - drug effects |
title | Cholinergic status modulations in human volunteers under acute inflammation |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T18%3A40%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cholinergic%20status%20modulations%20in%20human%20volunteers%20under%20acute%20inflammation&rft.jtitle=Journal%20of%20molecular%20medicine%20(Berlin,%20Germany)&rft.au=OFEK,%20Keren&rft.date=2007-11-01&rft.volume=85&rft.issue=11&rft.spage=1239&rft.epage=1251&rft.pages=1239-1251&rft.issn=0946-2716&rft.eissn=1432-1440&rft_id=info:doi/10.1007/s00109-007-0226-x&rft_dat=%3Cproquest_cross%3E68417775%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=217688902&rft_id=info:pmid/17657467&rfr_iscdi=true |